The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

NACompletedINTERVENTIONAL
Enrollment

397

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

June 15, 2023

Study Completion Date

September 15, 2023

Conditions
Tobacco CessationAsthma COPDBronchiectasis Adult
Interventions
OTHER

Immediate smoking cessation support

Smoker patients with chronic airway diseases (asthma and/or COPD and/or bronchiectasis) will be evaluated for the inclusion criteria. Afterwards they will be randomized as routine support arm (as the current procedure of the care) and immediate support arm (intensive brief cessation advices following by the immediate arrangement of the appointment from the same clinic's smoking cessation service). Both arms will be followed remotely at first week and third months of the randomization regarding their quit status as well as their use of evidence based cessation treatments.

Trial Locations (1)

Unknown

Recep Tayyip Erdoğan University, Training and Research Hospital, Rize

All Listed Sponsors
collaborator

Turkish Thoracic Society

OTHER

lead

Recep Tayyip Erdogan University Training and Research Hospital

OTHER